Research Paper Volume 14, Issue 24 pp 10050—10066
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
Figure 5. Control group, shSGOL2 + RAB1A-OE group, shSGOL2 group, RAB1A-OE group after transfecting with corresponding plasmids were subjected to the proliferation by Celigo cell counting assay in DU145 (A) and LNCaP (B), cell migration by transwell assay in DU145 (C) and LNCaP (D).